+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biological Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803374
  • Report
  • June 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squib
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • MORE
The report on the global biological drugs market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global biological drugs market to grow with a CAGR of 10.5% over the forecast period from 2019-2025. The study on biological drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on biological drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biological drugs market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global biological drugs market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Growing prevalence of cancer, diabetes and other major chronic illnesses
  • Rising investments in research and development of biological drugs
2) Restraints
  • Complexity in the manufacturing of biological drugs
3) Opportunities
  • Increasing demand for drugs with minimal side effects when compared to chemical drugs
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global biological drugs market is segmented on the basis of product type.

The Global Biological Drugs Market by Product Type
  • Therapeutic Protein
o Enbrel
o Lantus
o Neulasta
o Avones
o Novolog
o Rebif
o Humalog
o Other Therapeutic Protein
  • Monoclonal Antibody
o Humira
o Remicade
o Rituxan
o Avastin
o Herceptin
o Lucentis
o Other Monoclonal Antibodies
  • Vaccines
o Prevnar 13
o Gardasil
o Fluzone
o Varivax
o Cervarix
o Other Vaccines

Company Profiles
The companies covered in the report include
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squib
  • Biogen Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Other Companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the biological drugs market.
2. Complete coverage of all the segments in the biological drugs market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global biological drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squib
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Biological Drugs Market Highlights
2.2. Biological Drugs Market Projection
2.3. Biological Drugs Market Regional Highlights

3. Global Biological Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product Type
3.4.2. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Biological Drugs Market

4. Biological Drugs Market Macro Indicator Analysis

5. Global Biological Drugs Market by Product Type
5.1. Therapeutic Protein
5.1.1. Enbrel
5.1.2. Lantus
5.1.3. Neulasta
5.1.4. Avones
5.1.5. Novolog
5.1.6. Rebif
5.1.7. Humalog
5.1.8. Other Therapeutic Protein
5.2. Monoclonal Antibody
5.2.1. Humira
5.2.2. Remicade
5.2.3. Rituxan
5.2.4. Avastin
5.2.5. Herceptin
5.2.6. Lucentis
5.2.7. Other Monoclonal Antibodies
5.3. Vaccines
5.3.1. Prevnar 13
5.3.2. Gardasil
5.3.3. Fluzone
5.3.4. Varivax
5.3.5. Cervarix
5.3.6. Other Vaccines

6. Global Biological Drugs Market by Region 2019-2025
6.1. North America
6.1.1. North America Biological Drugs Market by Product Type
6.1.2. North America Biological Drugs Market by Country
6.2. Europe
6.2.1. Europe Biological Drugs Market by Product Type
6.2.2. Europe Biological Drugs Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Biological Drugs Market by Product Type
6.3.2. Asia-Pacific Biological Drugs Market by Country
6.4. RoW
6.4.1. RoW Biological Drugs Market by Product Type
6.4.2. RoW Biological Drugs Market by Sub-region

7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Biological Drugs Market
7.2. Companies Profiles
7.2.1. AbbVie Inc.
7.2.2. Amgen Inc.
7.2.3. Bristol-Myers Squibb
7.2.4. Biogen Inc.
7.2.5. F. Hoffmann-La Roche AG
7.2.6. Johnson & Johnson
7.2.7. Eli Lilly and Company
7.2.8. Merck & Co., Inc.
7.2.9. Novartis AG
7.2.10. Pfizer Inc.
7.2.11. Other Companies

8. Appendix
8.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squib
  • Biogen Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
Note: Product cover images may vary from those shown
Adroll
adroll